quinpirole has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, RW; Kostrzewa, RM; Thacker, SK; Thompson, KD; Thompson, KN; Ward, JJ; Williams, MT | 1 |
| Brown, RW; Maple, AM; Miller, BE; Perna, MK; Wilson, TD | 1 |
2 other study(ies) available for quinpirole and Cognition Disorders
| Article | Year |
|---|---|
Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression.
Topics: Acetylcholine; Animals; Animals, Newborn; Behavior, Animal; Brain Chemistry; Brain-Derived Neurotrophic Factor; Choline O-Acetyltransferase; Cognition Disorders; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Hippocampus; Humans; Male; Nerve Growth Factor; Nicotine; Nicotinic Agonists; Psychomotor Disorders; Psychomotor Performance; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Swimming; Time Factors; Yawning | 2004 |
Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates.
Topics: Acetylcholine; Aging; Animals; Animals, Newborn; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Choline O-Acetyltransferase; Cognition; Cognition Disorders; Dopamine Agonists; Down-Regulation; Female; Hippocampus; Learning Disabilities; Male; Maze Learning; Olanzapine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Time | 2008 |